Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Denali Capital Acquisition Corp. - Class A Ordinary Shares (NQ: DECA )

11.71 UNCHANGED
Streaming Delayed Price Updated: 10:16 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2
Open 11.71
Bid (Size) 11.71 (11)
Ask (Size) 11.90 (4)
Prev. Close 11.71
Today's Range 11.71 - 11.71
52wk Range 4.050 - 14.10
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Scilex Explores Strategic Options, Analyst Initiates On Blockbuster Potential For Sciatica Pain Candidate
Alliance Global Partners has initiated coverage on Scilex Holding Company. The company explores strategic options for its subsidiary, Scilex Pharma, including potential spinoffs and dividend... 
Via Benzinga

Performance

YTD
+6.17%
+6.17%
1 Month
+1.74%
+1.74%
3 Month
+1.56%
+1.56%
6 Month
+103.30%
+103.30%
1 Year
+6.65%
+6.65%

More News

Read More
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Non-Opioid Pain Therapy-Focused Semnur Pharmaceuticals Strikes $2B SPAC Deal For NASDAQ Debut
Via Benzinga
Correction: Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why GeneDx Holdings Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.